drugset / Trial / NCT00281281

Pharmacokinetics of Vancomycin in Adults Receiving ECMO

NCT00281281

Phase 4 Completed 24 enrolled National Taiwan University Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

1. Vancomycin is a drug that requires precise dosing and close monitoring to avoid drug toxicity. 2. There is limited data on the change of vancomycin pharmacokinetics in patients who need extracorporeal membrane oxygenation (ECMO). 3. This control trial is to understand: 1. whether the pharmacokinetics of vancomycin is influenced by the use ECMO 2. design the most appropriate dose of vancomycin in adult patients using ECMO.

Timeline

Start
2005-12
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified

Indications

No indication recorded.